Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.85 USD | -1.70% | -3.12% | -10.68% |
Apr. 11 | Harmony Biosciences, Bioprojet Enter Licensing Deal for Sleep Disorder Therapy | MT |
Apr. 03 | Harmony Biosciences Begins Phase 3 Trial of Pitolisant to Treat Prader-Willi Syndrome Symptoms | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.68% | 1.64B | |
+27.92% | 672B | |
+26.93% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+7.32% | 217B | |
+6.23% | 199B | |
-9.12% | 204B | |
-8.58% | 149B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Update: Harmony Biosciences Shares Jump After Q2 Gains Surprise, Blackstone Agrees to Provide Up to $330 Million in Financing